Research ArticleOpen AccessGoogle Scholar indexed
Antidepressant Activities of the Methanol Extract, Petroleum Ether and Ethyl Acetate Fractions of <i>Morus mesozygia</i> Stem Bark
Department of Pharmacognosy, Faculty of Pharmacy, Olabisi Onabanjo University, Sagamu Campus, Nigeria
Department of Pharmacognosy, Faculty of Pharmacy, Olabisi Onabanjo University, Sagamu Campus, Nigeria
- 1 Department of Pharmacognosy, Faculty of Pharmacy, Olabisi Onabanjo University, Sagamu Campus, Nigeria
- 2 Department of Pharmacognosy, Faculty of Pharmacy, Olabisi Onabanjo University, Sagamu Campus, Nigeria
Pharmacology & Pharmacy·Volume 04 (2013)·Pages 100–103·Published 1 January 2013·DOI10.4236/pp.2013.41014
Copy link · social · email
Abstract
Morus mesozygia Stapf (Moraceae) is the only Morus species indigenous to Tropical Africa. It is believed in traditional medicine that the plant exhibits several medicinal properties. The antidepressant-like activities of the crude methanol extract, petroleum ether and ethyl acetate fractions were investigated using the Forced Swimming Test (FST) and Tail Suspension Test (TST) models. The petroleum ether fraction at a dose of 140 mg/kg was the most effective in both the FST and TST when compared to the activity of the reference drug Imipramine (250 mg/kg) by reducing the immobility duration of the animals by 66.8% and 49.4% respectively.
Keywords<i>Morus mesozygia</i>Antidepressant ActivityForced Swimming TestTail Suspension Test
- H. M. Burkill, “The Useful Plants of West Tropical Africa,” Economic Botany & Ethnobotany, Vol. 1, 1985, p. 319.
- Z. O. Gbile, “Vernacular Names of Nigerian Plants (Yoruba),” Forestry Research Institute of Nigeria, Ibadan, 1984.
- G. D. W. F. Kapche, C. D. Fozing, J. H. Donfack, G. W. Fotso, D. Amadou, A. N. Tchana, M. Bezabih, P. F. Moundipa, B. T. Ngadjui and B. M. Abegaz, “Prenylated Arylbenzofuran Derivatives from Morus mesozygia with Antioxidant Activity,” Phytochemistry, Vol. 70, No. 2, 2009, pp. 216-221.
- G. W. D. Kapche, D. Amadou, P. Waffo-Teguo, J. H. Donfack, C. D. Fozing, D. Harakat, A. N. Tchana, J. M. Merillon, P. F. Moundipa, B. T. Ngadjul and B. M. Abegaz, “Hepatoprotective and Antioxidant Arylbenzofurans and Flavonoids from the Twigs of Morus mesozygia,” Planta Medica, Vol. 77, No. 10, 2011, pp. 1044-1047
- W. C. Evans, “Pharmacognosy,” 15th Edition, Saunders, London, 2009, p. 585.
- J. B. Haborne, “Method of Extraction and Isolation,” Phytochemical Methods, 3rd Edition, Chapman and Hall, London, 1998, pp. 60-66.
- V. K. Sharma, N. S. Chauhan, S. Lodhi and A. K. Singhai, “Anti-Depressant Activity of Zizyphus xylopyrus,” International Journal of Phytomedicine, Vol. 1, 2009, pp. 12-17. doi:10.5138/ijpm.2009.0975.0185.05788
- R. D. Porsolt, M. Le Pichon and M. Jalfre, “Depression: A New Animal Model Sensitive to Antidepressant Treatments,” Nature, Vol. 266, No. 5604, 1977, pp. 730-732.
- R. Porsolt, G. Anton and M. Jafre, “Behavioural Despair in Rats: A New Model Sensitive to Antidepressant Treatments,” European Journal of Pharmacology, Vol. 47, No. 4, 1978, pp. 379-391.
- L. Steru, R. Chermat, B. Thierry and P. Simon, “The Tail Suspension Test: A New Method for Screening Antidepressants in Mice,” Psychopharmacology, Vol. 85, No. 3, 1985, pp. 367-370.
- M. A. Whooley and G. E. Simon, “Managing Depression in Medical Outpatients,” New England Journal of Medicine, Vol. 343, 2000, pp. 1942-1950. doi:10.1056/NEJM200012283432607
- J. J. Schildkraut, “The Catecholamine Hypothesis of Effective Disorders: A Review of Supporting Evidence,” American Psychiatric Association, Vol. 122, No. 5, 1965, pp. 509-522.
- World Health Organization, “WHO Director-General Unveils New Global Strategies for Mental Health,” Press Release WHO/99-67, 1999. http://www.who.int/inf-pr-1999/en/pr99-67